Elekta AB EBITDA Margin 2013-2025 | EKTAY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Elekta AB (EKTAY) over the last 10 years. The current EBITDA margin for Elekta AB as of July 31, 2025 is .
| Elekta AB EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-07-31 | $1.59B | $0.25B | 15.45% |
| 2025-01-31 | $1.68B | $0.28B | 16.34% |
| 2024-10-31 | $1.69B | $0.28B | 16.37% |
| 2024-07-31 | $1.70B | $0.28B | 16.43% |
| 2024-04-30 | $1.71B | $0.30B | 17.54% |
| 2024-01-31 | $1.72B | $0.31B | 18.25% |
| 2023-10-31 | $1.70B | $0.30B | 17.42% |
| 2023-07-31 | $1.65B | $0.27B | 16.10% |
| 2023-04-30 | $1.61B | $0.24B | 14.75% |
| 2023-01-31 | $1.58B | $0.23B | 14.65% |
| 2022-10-31 | $1.56B | $0.24B | 15.04% |
| 2022-07-31 | $1.61B | $0.28B | 17.57% |
| 2022-04-30 | $1.64B | $0.30B | 18.38% |
| 2022-01-31 | $1.61B | $0.30B | 18.81% |
| 2021-10-31 | $1.64B | $0.33B | 20.34% |
| 2021-07-31 | $1.61B | $0.34B | 21.22% |
| 2021-04-30 | $1.58B | $0.36B | 22.60% |
| 2021-01-31 | $1.56B | $0.36B | 23.34% |
| 2020-10-31 | $1.51B | $0.35B | 23.12% |
| 2020-07-31 | $1.49B | $0.32B | 21.22% |
| 2020-04-30 | $1.52B | $0.30B | 20.05% |
| 2020-01-31 | $1.55B | $0.32B | 20.31% |
| 2019-10-31 | $1.54B | $0.30B | 19.28% |
| 2019-07-31 | $1.52B | $0.30B | 19.78% |
| 2019-04-30 | $1.50B | $0.29B | 19.51% |
| 2019-01-31 | $1.49B | $0.29B | 19.62% |
| 2018-10-31 | $1.46B | $0.30B | 20.25% |
| 2018-07-31 | $1.43B | $0.29B | 20.29% |
| 2018-04-30 | $1.37B | $0.27B | 19.55% |
| 2018-01-31 | $1.35B | $0.25B | 18.32% |
| 2017-10-31 | $1.32B | $0.22B | 16.95% |
| 2017-07-31 | $1.25B | $0.20B | 16.28% |
| 2017-04-30 | $1.23B | $0.20B | 16.57% |
| 2017-01-31 | $1.23B | $0.23B | 18.80% |
| 2016-10-31 | $1.24B | $0.19B | 15.60% |
| 2016-07-31 | $1.29B | $0.20B | 15.81% |
| 2016-04-30 | $1.33B | $0.20B | 14.79% |
| 2016-01-31 | $1.35B | $0.14B | 10.57% |
| 2015-10-31 | $1.36B | $0.16B | 11.96% |
| 2015-07-31 | $1.37B | $0.15B | 10.71% |
| 2015-04-30 | $1.37B | $0.11B | 8.08% |
| 2015-01-31 | $1.49B | $0.20B | 13.32% |
| 2014-10-31 | $1.55B | $0.23B | 14.95% |
| 2014-07-31 | $1.58B | $0.25B | 16.09% |
| 2014-04-30 | $1.60B | $0.30B | 18.86% |
| 2014-01-31 | $1.59B | $0.37B | 23.40% |
| 2013-10-31 | $1.60B | $0.38B | 23.67% |
| 2013-07-31 | $1.60B | $0.38B | 23.72% |
| 2013-04-30 | $1.55B | $0.36B | 22.97% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.162B | $1.708B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $216.122B | 25.68 |
| Intuitive Surgical (ISRG) | United States | $203.841B | 79.75 |
| IDEXX Laboratories (IDXX) | United States | $57.291B | 56.90 |
| Edwards Lifesciences (EW) | United States | $49.778B | 33.38 |
| Alcon (ALC) | Switzerland | $38.961B | 26.33 |
| IQVIA Holdings (IQV) | United States | $38.304B | 21.36 |
| Mettler-Toledo (MTD) | United States | $29.066B | 34.01 |
| STERIS (STE) | Ireland | $25.618B | 26.45 |
| DexCom (DXCM) | United States | $25.449B | 35.08 |
| Waters (WAT) | United States | $23.598B | 31.21 |
| Hologic (HOLX) | United States | $16.687B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.793B | 0.00 |
| Globus Medical (GMED) | United States | $11.877B | 24.93 |
| Penumbra (PEN) | United States | $11.542B | 81.19 |
| Masimo (MASI) | United States | $7.641B | 24.49 |
| Glaukos (GKOS) | United States | $6.252B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.973B | 18.98 |
| Teleflex (TFX) | United States | $5.253B | 8.37 |
| TransMedics (TMDX) | United States | $4.738B | 56.13 |
| Veracyte (VCYT) | United States | $3.748B | 42.71 |
| LivaNova (LIVN) | United Kingdom | $3.489B | 18.85 |
| Alphatec Holdings (ATEC) | United States | $3.161B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.474B | 11.61 |
| Artivion (AORT) | United States | $2.151B | 98.72 |
| PROCEPT BioRobotics (PRCT) | United States | $1.980B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.740B | 15.19 |
| UFP Technologies (UFPT) | United States | $1.668B | 22.02 |
| AxoGen (AXGN) | United States | $1.515B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.321B | 0.00 |
| IRadimed (IRMD) | United States | $1.195B | 56.92 |
| Integra LifeSciences Holdings (IART) | United States | $1.057B | 5.73 |
| OPKO Health (OPK) | United States | $1.036B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.899B | 0.00 |
| SiBone (SIBN) | United States | $0.835B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.761B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.630B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.599B | 34.82 |
| NeuroPace (NPCE) | United States | $0.565B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.561B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.517B | 10.31 |
| RxSight (RXST) | United States | $0.514B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.456B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.441B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.426B | 11.76 |
| ClearPoint Neuro (CLPT) | United States | $0.400B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.354B | 58.94 |
| Alpha Tau Medical (DRTS) | Israel | $0.344B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.250B | 0.00 |
| CVRx (CVRX) | United States | $0.245B | 0.00 |
| 908 Devices (MASS) | United States | $0.241B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.187B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.179B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.175B | 0.00 |
| Solana (HSDT) | United States | $0.173B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.165B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.146B | 0.00 |
| LENSAR (LNSR) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.116B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Neuronetics (STIM) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Hyperfine (HYPR) | United States | $0.096B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.090B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.081B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.066B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.020B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.24 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |